Honorary Fellows are elected for life by the British Pharmacological Society in recognition of sustained excellence and leadership in science, healthcare, and public service.
The Honorary Fellowship includes Nobel Laureates, international prize-winners, long-standing members of the Society, and those who have advanced the disciplines of Pharmacology, Clinical Pharmacology and Therapeutics through research, leadership and contribution to the British Pharmacological Society.
Find out more and nominate individuals for Honorary Fellowship.
This Directory has been created to increase the visibility of our Honorary Fellows and their contributions, and to support networking by providing a useful resource for members to connect with Honorary Fellows with similar areas of interest.
Here you can find profiles of each Honorary Fellow, including information on their institutional affiliation, year elected, primary professional setting, Affinity Group membership, along with a short biography.
Please click the magnifying glass icon to begin any searches.
Roland Jones began his career with a BSc in Pharmacology at the University of Bradford (1971-75) where he was inspired to become a neuropharmacologist by Bob Naylor and a year on placement in the “Mood Modifier” project at Beechams in Harlow.
Prof Jones is Chairman of the international Clinical Research Organisation, Simbec-Orion and Board member of the Global Life Sciences investment company; Arix Bioscience; the Oxford based Drug Discovery Company ,e-Therapeutics; and the UK Stem Cell Foundation (UKSCF).
Eamonn obtained a BSc at the University of Sheffield in 1981, then undertook a PhD in Neuropharmacology at the Institute of Psychiatry and King’s College Hospital in London.
Kelly, Professor John Shearer; Educ: George Heriot's School, Edinburgh, Edinburgh University 1965-68 Deg: BSc (Edin) 1960, MB ChB 1962, PhD (Edin) 1966, MA (Cantab) 1976.
Since March 2022, Catherine (Katy) Kettleborough has headed up LifeArc’s Chronic Respiratory Infection Translational Challenge.
Professor Kitchen is CEO of REF2020 Consulting and retired Emeritus Professor of Neuropharmacology at the University of Surrey.
Brian Kobilka, MD is Professor of Molecular and Cellular Physiology, and Hélène Irwin Fagan Chair in Cardiology at Stanford University School of Medicine.
Professor Andrew Lawrence is an NHMRC Principal Research Fellow & Division Head at the Florey Institute of Neuroscience & Mental Health where he is leader of the Mental Health Research Theme and runs the Addiction Neuroscience laboratory.
A native of Glasgow, David was educated at the High School of Glasgow and Glasgow University (MB 62, MD 73), and became Consultant Physician and Clinical Pharmacologist in Glasgow Royal Infirmary in 1973.
Robert Lechler qualified in Medicine and trained in general medicine and nephrology.